Clinical Trial Update: A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update of apatinib plus docetaxel for advanced non-squamous non-small cell lung cancer with bone metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Affiliated Hospital of Hebei University | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN